National Biomedical Research Centers (P50 Clinical Trial Optional)
Forecast — expected to open 25 Nov 2026
National Institutes of Health expects to make 2 awards of $7.96 million – $11.41 million each. This is a forecast: the funder has announced the opportunity but it is not open yet; posting is expected around 25 Nov 2026 and the estimated deadline is 25 Jan 2027. Eligible applicant types include state governments, nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education and 12 more.
Deadline
Estimated 25 Jan 2027 (not yet confirmed)
Opens
25 Nov 2026
Grant amount
$7.96 million – $11.41 million per project
Funding rate
No mandatory cost sharing stated; funding percentage not stated
Expected awards
2
Cost sharing
Not required
Likely applicant types
Public bodies, Non-profits, Universities & research, SMEs / start-ups, Companies From source categories or programme rules; the call decides.
The National Biomedical Research Centers (NBRCs) are expected to provide scientific expertise, advanced equipment, infrastructure, and a range of well-characterized research models to researchers across the nation. Research at the NBRCs is supported by almost all NIH Institutes, as well as other federal agencies, including those that safeguard US national security interests. This NOFO emphasizes development of innovative human-based models and new technologies to reduce reliance on live research models. Applications must describe clear, actionable plans to reduce, refine, and replace whole-animal use by developing complementary and alternative approaches tailored to relevant use cases in biomedical research. Scientifically, the NBRCs function as centers of innovation in fundamental science as well as translational hubs that develop, refine, and test novel interventions for ultimate use in human patients. It is NIH’s intention that the NBRCs become leaders in the development and use of human-based approaches, including sophisticated in vitro and in silico models, known as New Approach Methodologies (NAMs). Clinical trials are allowed only as human-based NAMs, where applicable. This notice of funding opportunity (NOFO) is an open competition to increase opportunities for innovation, including NAMs research, at research centers with existing nonhuman primate colonies, and to further leverage existing capabilities in basic and translational research.
Who can apply
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
Private institutions of higher education
Special district governments
Small businesses
For profit organizations other than small businesses
City or township governments
Applicant categories are a starting point. The official call decides eligibility.
Topics
Health
How to apply
Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
For NIH: the organisation and the principal investigator also need eRA Commons accounts; applications are usually submitted through Grants.gov (for example with ASSIST).
Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
Submit before the deadline and keep the tracking number. Check for amendments before you submit.
From the call text
Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Not stated in the call text we hold — check the official page
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Not stated in the call text we hold — check the official page
Contact
Division of Comparative Medicine, Office of Research Infrastructure Programs · ORIPDCM@mail.nih.gov · 301-451-2074
Where these facts come from
Fact
Value
How we know
Taken from the source
Deadline
25 January 2027
official data field
15 Nov 2026
Amount per applicant
$7.96 million – $11.41 million
official data field
15 Nov 2026
Total budget
Unknown — not stated in the source we hold
unknown
—
Funding rate
No mandatory cost sharing stated; funding percentage not stated
read from the official text
15 Nov 2026
Who can apply
State governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher…
Facts on this page come from the funder’s official data, taken on 15 Nov 2026. The funder's own documents, including later amendments, always take precedence.
The purpose of this Notice of Funding Opportunity (NOFO) is to invite Small Research Grant (R21) applications that propose to study the ethical, legal, and social implica…
The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative health approaches with physical and/or psychologic…
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to assess the efficacy…
This notice of funding opportunity (NOFO) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical…
This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The inten…